In a following cohort study by Makavos et al., anti-IL-17 treatment was compared to conventional treatment with cyclosporine or methotrexate regarding their ability to improve myocardial deformation and vascular function in moderate–severe psoriasis [80]. Here, IL17A is linked to psoriasis.